215 related articles for article (PubMed ID: 9858615)
1. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest.
Iavarone A; Massagué J
Mol Cell Biol; 1999 Jan; 19(1):916-22. PubMed ID: 9858615
[TBL] [Abstract][Full Text] [Related]
2. Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.
Chen X; Prywes R
Mol Cell Biol; 1999 Jul; 19(7):4695-702. PubMed ID: 10373518
[TBL] [Abstract][Full Text] [Related]
3. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
4. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
5. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
[TBL] [Abstract][Full Text] [Related]
6. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
8. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.
Rayman JB; Takahashi Y; Indjeian VB; Dannenberg JH; Catchpole S; Watson RJ; te Riele H; Dynlacht BD
Genes Dev; 2002 Apr; 16(8):933-47. PubMed ID: 11959842
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
10. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.
Thomas NS; Pizzey AR; Tiwari S; Williams CD; Yang J
J Biol Chem; 1998 Sep; 273(37):23659-67. PubMed ID: 9726970
[TBL] [Abstract][Full Text] [Related]
11. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
12. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.
Vigo E; Müller H; Prosperini E; Hateboer G; Cartwright P; Moroni MC; Helin K
Mol Cell Biol; 1999 Sep; 19(9):6379-95. PubMed ID: 10454584
[TBL] [Abstract][Full Text] [Related]
13. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
14. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.
Moberg K; Starz MA; Lees JA
Mol Cell Biol; 1996 Apr; 16(4):1436-49. PubMed ID: 8657117
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.
Vairo G; Soos TJ; Upton TM; Zalvide J; DeCaprio JA; Ewen ME; Koff A; Adams JM
Mol Cell Biol; 2000 Jul; 20(13):4745-53. PubMed ID: 10848600
[TBL] [Abstract][Full Text] [Related]
16. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA
Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo.
Bouzahzah B; Fu M; Iavarone A; Factor VM; Thorgeirsson SS; Pestell RG
Cancer Res; 2000 Aug; 60(16):4531-7. PubMed ID: 10969803
[TBL] [Abstract][Full Text] [Related]
19. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
Timchenko NA; Wilde M; Iakova P; Albrecht JH; Darlington GJ
Nucleic Acids Res; 1999 Sep; 27(17):3621-30. PubMed ID: 10446255
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
Katich SC; Zerfass-Thome K; Hoffmann I
Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]